Marshall Wace North America’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-6,521
Closed -$1.17M – 1650
2021
Q1
$1.17M Buy
6,521
+3,460
+113% +$638K ﹤0.01% 993
2020
Q4
$564K Buy
3,061
+363
+13% +$59.7K ﹤0.01% 1065
2020
Q3
$406K Buy
+2,698
New +$423K ﹤0.01% 1011
2019
Q1
– Sell
-1,248
Closed -$238K – 1780
2018
Q4
$238K Buy
+1,248
New +$243K ﹤0.01% 925
2018
Q3
– Sell
-15,418
Closed -$3.41M – 1203
2018
Q2
$3.41M Buy
+15,418
New +$2.85M 0.02% 617
2017
Q4
– Sell
-7,241
Closed -$1.1M – 1519
2017
Q3
$1.1M Sell
7,241
-2,431
-25% -$368K 0.01% 924
2017
Q2
$1.36M Buy
+9,672
New +$1.37M 0.01% 839
2013
Q4
$9.21M Buy
+224,191
New +$9.13M 0.19% 125

Other funds holding MSGS

Marshall Wace North America's MSGS Position: Q2 2021 in Review

Marshall Wace North America sold out of Madison Square Garden (MSGS) in Q2 2021, closing a stake of 6,521 shares — an estimated $1.17M sold.

Marshall Wace North America first reported a position in MSGS in Q4 2013 and held it in 8 quarters. The position peaked at $9.21M in Q4 2013. 275 funds tracked by Wall St. Rank hold MSGS as of Q2 2021.

  • Marshall Wace North America reported no remaining Madison Square Garden position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 6,521 Madison Square Garden shares in Q2 2021, an estimated $1.17M.
  • Marshall Wace North America first reported a position in Madison Square Garden in Q4 2013 and held it in 8 quarters.
  • Marshall Wace North America's Madison Square Garden position peaked at $9.21M in Q4 2013.
  • 275 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.